全文获取类型
收费全文 | 592篇 |
免费 | 61篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 27篇 |
妇产科学 | 10篇 |
基础医学 | 67篇 |
口腔科学 | 14篇 |
临床医学 | 26篇 |
内科学 | 135篇 |
皮肤病学 | 8篇 |
神经病学 | 20篇 |
特种医学 | 3篇 |
外科学 | 229篇 |
综合类 | 8篇 |
预防医学 | 34篇 |
眼科学 | 24篇 |
药学 | 29篇 |
中国医学 | 1篇 |
肿瘤学 | 19篇 |
出版年
2023年 | 2篇 |
2022年 | 7篇 |
2021年 | 16篇 |
2020年 | 17篇 |
2019年 | 32篇 |
2018年 | 29篇 |
2017年 | 24篇 |
2016年 | 17篇 |
2015年 | 16篇 |
2014年 | 20篇 |
2013年 | 44篇 |
2012年 | 48篇 |
2011年 | 54篇 |
2010年 | 30篇 |
2009年 | 21篇 |
2008年 | 34篇 |
2007年 | 37篇 |
2006年 | 38篇 |
2005年 | 31篇 |
2004年 | 21篇 |
2003年 | 16篇 |
2002年 | 13篇 |
2001年 | 7篇 |
2000年 | 6篇 |
1999年 | 6篇 |
1998年 | 3篇 |
1997年 | 2篇 |
1996年 | 2篇 |
1993年 | 3篇 |
1992年 | 3篇 |
1988年 | 6篇 |
1986年 | 3篇 |
1980年 | 1篇 |
1979年 | 3篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1974年 | 2篇 |
1973年 | 4篇 |
1972年 | 5篇 |
1971年 | 5篇 |
1970年 | 3篇 |
1969年 | 1篇 |
1968年 | 1篇 |
1967年 | 1篇 |
1966年 | 3篇 |
1965年 | 2篇 |
1964年 | 1篇 |
1962年 | 2篇 |
1960年 | 2篇 |
1947年 | 1篇 |
排序方式: 共有656条查询结果,搜索用时 46 毫秒
11.
Holdcraft LC Assefi N Buchwald D 《Best Practice & Research: Clinical Rheumatology》2003,17(4):667-683
Complementary and alternative medicine (CAM) has gained increasing popularity, particularly among individuals with fibromyalgia syndrome (FMS) for which traditional medicine has generally been ineffective. A systematic review of randomized controlled trials (RCTs) and non-RCTs on CAM studies for FMS was conducted to evaluate the empirical evidence for their effectiveness. Few RCTs achieved high scores on the CONSORT, a standardized evaluation of the quality of methodology reporting. Acupuncture, some herbal and nutritional supplements (magnesium, SAMe) and massage therapy have the best evidence for effectiveness with FMS. Other CAM therapies have either been evaluated in only one RCT with positive results (Chlorella, biofeedback, relaxation), in multiple RCTs with mixed results (magnet therapies), or have positive results from studies with methodological flaws (homeopathy, botanical oils, balneotherapy, anthocyanidins, dietary modifications). Lastly, other CAM therapies have neither well-designed studies nor positive results and are not currently recommended for FMS treatment (chiropractic care). 相似文献
12.
13.
14.
Youakim Saliba Ralph Karam Viviane Smayra Georges Aftimos Joel Abramowitz Lutz Birnbaumer Nassim Farès 《Journal of the American Society of Nephrology : JASN》2015,26(8):1855-1876
Transient receptor potential canonical (TRPC) Ca2+-permeant channels, especially TRPC3, are increasingly implicated in cardiorenal diseases. We studied the possible role of fibroblast TRPC3 in the development of renal fibrosis. In vitro, a macromolecular complex formed by TRPC1/TRPC3/TRPC6 existed in isolated cultured rat renal fibroblasts. However, specific blockade of TRPC3 with the pharmacologic inhibitor pyr3 was sufficient to inhibit both angiotensin II- and 1-oleoyl-2-acetyl-sn-glycerol–induced Ca2+ entry in these cells, which was detected by fura-2 Ca2+ imaging. TRPC3 blockade or Ca2+ removal inhibited fibroblast proliferation and myofibroblast differentiation by suppressing the phosphorylation of extracellular signal-regulated kinase (ERK1/2). In addition, pyr3 inhibited fibrosis and inflammation-associated markers in a noncytotoxic manner. Furthermore, TRPC3 knockdown by siRNA confirmed these pharmacologic findings. In adult male Wistar rats or wild-type mice subjected to unilateral ureteral obstruction, TRPC3 expression increased in the fibroblasts of obstructed kidneys and was associated with increased Ca2+ entry, ERK1/2 phosphorylation, and fibroblast proliferation. Both TRPC3 blockade in rats and TRPC3 knockout in mice inhibited ERK1/2 phosphorylation and fibroblast activation as well as myofibroblast differentiation and extracellular matrix remodeling in obstructed kidneys, thus ameliorating tubulointerstitial damage and renal fibrosis. In conclusion, TRPC3 channels are present in renal fibroblasts and control fibroblast proliferation, differentiation, and activation through Ca2+-mediated ERK signaling. TRPC3 channels might constitute important therapeutic targets for improving renal remodeling in kidney disease. 相似文献
15.
Cdric Farges Olivier Cointault Marlne Murris Laurence Lavayssiere Shrazade Lakhdar‐Ghazal Arnaud Del Bello Anne‐Laure Hebral Laure Esposito Marie‐Batrice Nogier Federico Sallusto Xavier Iriart Elena Charpentier Joelle Guitard Fabrice Muscari Camille Dambrin Lydie Porte Nassim Kamar Sophie Cassaing Stanislas Faguer 《Transplant infectious disease》2020,22(1)
16.
17.
Mayanja BN Shafer LA Van der Paal L Kyakuwa N Ndembi N Hughes P Maher D Grosskurth H 《Tropical medicine & international health : TM & IH》2012,17(3):343-352
Objectives Before antiretroviral therapy (ART) introduction, pregnancy was associated with a sustained drop in CD4 cell count in HIV‐infected women. We examined the effects of pregnancy on immunological and virological ART outcomes. Methods Between January 2004 and March 2009, we studied HIV‐infected women receiving ART in a prospective open cohort study in rural Uganda. We used random effects regression models to compare the CD4 counts of women who became pregnant and those who did not, and among the pregnant women before and after pregnancy. CD4 count and proportions with detectable viral load (≥400 copies/ml) were compared between the two groups using the Mann–Whitney rank sum test and logistic regression respectively. Results Of 88 women aged 20–40 years receiving ART, 23 became pregnant. At ART initiation, there were no significant differences between those who became pregnant and those who did not in clinical, immunological and virological parameters. Among women who became pregnant, CD4 cell count increased before pregnancy (average 75.9 cells/mm3 per year), declined during pregnancy (average 106.0) but rose again in the first year after delivery (average 88.6). Among women who did not become pregnant, the average CD4 cell count rise per year for the first 3 years was 88.5. There was no significant difference in the proportions of women with detectable viral load at last clinic visit among those who became pregnant (8.7%) and those who did not (16.1%), P = 0.499. Conclusion Pregnancy had no lasting effect on the immunological and virological outcomes of HIV‐infected women on ART. 相似文献
18.
19.
G. Canaud N. Kamar D. Anglicheau L. Esposito M. Rabant L.‐H. Noël C. Guilbeau‐Frugier R. Sberro‐Soussan A. Del Bello F. Martinez J. Zuber L. Rostaing C. Legendre 《American journal of transplantation》2013,13(8):2179-2185
Thrombotic microangiopathy (TMA) is one of the hallmark vascular lesions of antiphospholipid syndrome nephropathy (APSN). These lesions are at high risk of recurrence after kidney transplantation. The complement pathway is thought to be active in this process. We used eculizumab to treat three consecutive kidney transplant recipients with posttransplant TMA due to APSN recurrence that was resistant to plasmapheresis and explored the complement deposition and apoptotic and vascular cell markers on the sequential transplant biopsies. Treatment with eculizumab resulted in a rapid and dramatic improvement of the graft function in all three patients and in improvement of the TMA lesions within the graft. None of these patients had TMA flares after eculizumab was withdrawn. At the time of TMA diagnosis, immunofluorescence studies revealed intense C5b‐9 and C4d depositions at the endothelial cell surface of the injured vessels. Moreover, C5b‐9 colocalized with vessels exhibiting a high rate of apoptotic cells. Examination of sequential biopsies during eculizumab therapy showed that TMA lesions, C4d and apoptotic markers were rapidly cleared but the C5b‐9 deposits persisted for several months as a footprint of the TMA. Finally, we noticed that complement inhibition did not prevent the development of the chronic vascular changes associated with APSN. Eculizumab seems to be an efficient method for treating severe forms of posttransplant TMA due to APSN recurrence. Terminal complement inhibition does not prevent the development of chronic APSN. 相似文献